Editorially Independent Content, Supported with Advertising from Allergan XEN, Glaukos iDose & Nova Eye.
Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD
Show Description +
In this case discussion, Manjool Shah, MD, describes a patient with glaucoma who had previously undergone successful tube shunt surgery in her right eye and was now losing vision in her left eye. Dr. Shah explains why he decided the Xen Gel Stent (AbbVie) was the most appropriate intervention for this patient and why a tube shunt was not an option due to the patient’s scleral integrity. Joseph F. Panarelli, MD, and Arsham Sheybani, MD, share additional insights into patient selection and how to determine appropriate treatment strategies. Dr. Shah further explains his preferred placement technique for Xen Gel Stent implantation.
Posted: 6/07/2024
Joseph F. Panarelli, MD; Manjool Shah, MD; and Arsham Sheybani, MD
In this case discussion, Manjool Shah, MD, describes a patient with glaucoma who had previously undergone successful tube shunt surgery in her right eye and was now losing vision in her left eye. Dr. Shah explains why he decided the Xen Gel Stent (AbbVie) was the most appropriate intervention for this patient and why a tube shunt was not an option due to the patient’s scleral integrity. Joseph F. Panarelli, MD, and Arsham Sheybani, MD, share additional insights into patient selection and how to determine appropriate treatment strategies. Dr. Shah further explains his preferred placement technique for Xen Gel Stent implantation.
Posted: 6/07/2024
Please log in to leave a comment.